Original Research

Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States

Jara M, Aquilina T, Aupperle P, Rabinowicz AL

Drug, Healthcare and Patient Safety 2015, 7:169-174

Published Date: 15 December 2015